Second Targeted Therapeutic Approved for Use Based on Tumor Biomarker, Not Tumor Origin
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
As a monthly staple on this blog, we feature the editors’ picks from the 10 journal issues published by...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
Decades of research have led to the identification of an increasing number of cancer-causing substances in our environment. These...
In the past year, the number of American teenagers using tobacco products has increased by nearly 40 percent, reversing...
Metastasis is defined as the spreading of cancer cells from the place where they first formed to another part...
On Saturday, May 4, Philadelphians flooded the Benjamin Franklin Parkway for the Franklin Institute’s ninth annual Philadelphia Science Festival....
Since the 1990s, the cancer mortality rate in the U.S. has steadily declined. Yet liver cancer death rates in...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...